Payment & Shipping Terms:
|Molecular Formula::||200-600-4||Melting Point:||285-290°c|
|Appearance:||White Crystalline Powder,||Email:||Gavin@pharmrich.com|
65-19-0 Sex Steroid Hormones,
200-600-4 Sex Steroid Hormones,
|Product name||Yohimbine Hydrochloride(Yohimbe HCl)|
|Synonyms||Actibine; Antagonil; Yohimbe; Yohimbine monohydrochloride; Yohimex; Yohimbe Bark Extract|
|Molecular Formula||C21H26N2O3. ClH|
|Appearance||White to creamy white fine powder|
|Melting Point||288-290 ° C|
|Boiling Point||543 ° C at 760 mmHg|
|Flash Point||282.2 ° C|
|Storage||Sealed, light and oxygen resistant|
|Usage||Increase muscular tension or urinary function no damage sex; Accelerate human body energy metabolism, increase energy supply.|
Injectable Yohimbine Hcl
1g yo hcl.
1. Yohimbine hydrochloride is indicated as a sympathicolytic and mydriatic. It may have activity as an aphrodisiac.
Impotence (not able to have erections)
To work by increasing the body's production of certain chemicals that help produce erections. It does not work in all men who are impotent.
New research that shows it could be an herb with very effective antioxidant potential. Research shows it is a vasodilator, which means that it increases blood flow to the extremities and appendages.
2. Yohimbine readily penetrates the (CNS) and produces a complex pattern of responses in lower doses than those required to produce peripheral alpha-adrenergic blockade. These include, anti-diuresis, a general picture of central excitation including elevation of blood pressure and heart rate, increased motor activity, nervousness, irritability and tremor. Sweating, nausea and vomiting are common after parenteral administration of the drug. Also, dizziness, headache skin flushing reported when used orally.
3. Generally, this drug is not proposed for use in females and certainly must not be used during pregnancy. Neither is this drug proposed for use in pediatric, geriatric or cardio-renal patients with gastric or duodenal ulcer history. Nor should it be used in conjunction with mood- modifying drugs such as antidepressants, or in psychiatric patients in general.
Contact Person: Gavin Lee